Previous 10 | Next 10 |
home / stock / bsx / bsx articles
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry obse...
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 8.59% on an annualized basis producing an average annual return ...
West Pharmaceutical Services, Inc. (NYSE: WST) is well poised for growth, backed by the robust Proprietary Products segment and sustained strength ...
McKesson Corporation's (NYSE: MCK) Biologics by McKesson, its independent specialty pharmacy specializing in oncology and rare disease areas, h...
The Zacks Medical – Products industry's revenues are expected to continue its growth trajectory on the back of the recovery in demand for...
BrainsWay Ltd. (NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute ho...
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports abo...
Tuesday, Boston Scientific Corporation (NYSE:BSX) agreed to acquire Silk Road Medical Inc (NASDAQ:SILK) for $27.50 in cash per share, representing ...
SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a leading shareholder rights law firm, announced today that it has initiated a...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...
2024-07-08 14:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for BSX on July 2, 2024 08:01AM ET. The previous analyst recommendation was Outperform. BSX was trading at $76.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...